Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 13 2025 | First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study Industry News In The News Industry Read More May 12 2025 | BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC Industry News In The News Industry Read More May 4 2025 | HFSA President's Update: May 2025 HFSA News President's Updates Read More May 1 2025 | Welcoming April's New HFSA Members HFSA News Membership Read More Apr 28 2025 | Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Next › Last page Last »
May 13 2025 | First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study Industry News In The News Industry Read More
May 12 2025 | BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC Industry News In The News Industry Read More
Apr 28 2025 | Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase Industry News In The News Industry Read More
